December 1 - 6, 2024
Boston, Massachusetts
Symposium Supporters
2024 MRS Fall Meeting & Exhibit
SB05.01.06

In Vitro Validation of PEDOT:PSS 3D Printed Conductive Hydrogels as Promotors of Angiogenesis and Wound-Healing in Diabetic Foot Ulcers (DFU)

When and Where

Dec 3, 2024
11:00am - 11:15am
Hynes, Level 3, Room 312

Presenter(s)

Co-Author(s)

Luis Lozano1,Andrea Madrigal1,Atzin Alcaraz1,Alexandra Huerta1,Tania Hernandez1,Laura Cardenas1

Tecnológico de Monterrey1

Abstract

Luis Lozano1,Andrea Madrigal1,Atzin Alcaraz1,Alexandra Huerta1,Tania Hernandez1,Laura Cardenas1

Tecnológico de Monterrey1
Diabetic foot ulcers (DFUs) represent a significant healthcare challenge worldwide for patients with diabetes Mellitus. These wounds are associated with poor glycemic control, vascular disease, and underlying neuropathies. Alongside impaired wound healing and bacterial infection biofilms, DFUs often become a chronic disease that can lead to severe complications such as osteomyelitis and lower limb amputations. In this research project, we propose an innovative therapeutic strategy, applying polymeric conductive 3D-printed hydrogels to promote angiogenesis and improve wound healing in DFUs. These hydrogels, composed of biocompatible polymers, offer a combination of electrical conductivity and mechanical properties suitable for wound healing applications. The conductive properties of the hydrogels facilitate electrical stimulation at the wound site, promoting cell proliferation, angiogenesis, tissue regeneration, and inhibiting bacterial growth. The antimicrobial activity of the hydrogel is of high relevance, as progressed polymicrobial biofilms become drug-resistant and can lead to treatment failure. Additionally, the 3D printing technology allows for precise customization of the hydrogel scaffolds, ensuring optimal fit and coverage of the ulcerated area.<br/><br/>At this stage, the project aims to investigate the efficacy of conductive 3D-printed hydrogels in promoting wound healing and preventing complications associated with DFUs through in vitro experiments in hyperglycemia conditions. Additionally, biocompatibility and long-term safety assessments will be conducted to evaluate the feasibility of clinical translation. The outcomes of this research can potentially translate into improved therapeutic approaches in the management of DFUs, offering a promising addition to the current standard treatment and improving the quality of life for diabetic patients.<br/><br/>This research project has been supported by the Challenge Research Funding Program of Tecnologico de Monterrey.

Keywords

3D printing | polymer

Symposium Organizers

Gulden Camci-Unal, University of Massachusetts Lowell
Michelle Oyen, Washington University in St. Louis
Natesh Parashurama, University at Buffalo, The State University of New York
Janet Zoldan, The University of Texas at Austin

Session Chairs

Gulden Camci-Unal
Natesh Parashurama

In this Session